CA Patent

CA3088328A1 — Pyruvate kinase activators for use in therapy

Assigned to Agios Pharmaceuticals Inc · Expires 2012-11-08 · 14y expired

What this patent protects

ABSTRACT Described herein are methods for using compounds that activate pyruvate kinase. Date Recue/Date Received 2020-07-29

USPTO Abstract

ABSTRACT Described herein are methods for using compounds that activate pyruvate kinase. Date Recue/Date Received 2020-07-29

Drugs covered by this patent

Patent Metadata

Patent number
CA3088328A1
Jurisdiction
CA
Classification
—
Expires
2012-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.